Warner Chilcott faces Femcon challenge |
|
|
|
Published
:
Wed, 15 Aug 2007 15:37
|
ROCKAWAY, N.J. (AP) - Drug developer Warner Chilcott Ltd. said Wednesday it received notice of a patent challenge from Barr Pharmaceuticals Inc. over the company's chewable birth control pill Femcon FE.Warner launched the oral contraceptive in 2006. It is a chewable version of the birth control pill Ovcon 35, which has been on the market for decades. Watson Pharmaceuticals makes a generic version of that drug.The patent challenge comes as Barr's subsidiary Barr Laboratories files an application with the Food and Drug Administration to make a generic version of Femcon FE. Warner Chilcott said Femcon FE is under patent protection until 2019 and that it continues to have full confidence in that patent protection.Shares of Warner Chilcott fell 51 cents, or 2.9 percent, to $17.41 in morning trading. The stock has traded between $12.72 and $20.02 over the last 52 weeks. Shares of Barr were unchanged at $53.68.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Time Warner Q2 earnings rise; announces 5 bln usd share buyback 